Selective BET Protein Inhibition with Apabetalone and Cardiovascular Events: A Pooled Analysis of Trials in Patients with Coronary Artery Disease
Crossref DOI link: https://doi.org/10.1007/s40256-017-0250-3
Published Online: 2017-10-12
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nicholls, Stephen J.
Ray, Kausik K.
Johansson, Jan O.
Gordon, Alan
Sweeney, Michael
Halliday, Chris
Kulikowski, Ewelina
Wong, Norman
Kim, Susan W.
Schwartz, Gregory G.
Funding for this research was provided by:
Resverlogix
License valid from 2017-10-12